VXRT · Vaxart, Inc.
$0.54
-0.02 (-2.95%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern for a period of one year from the date of the issuance of these consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$131.13M
Shares
242.84M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven Lo | President and Chief Executive Officer | $2,085,768 |
| Andrei Floroiu | CEO | $1,931,356 |
| James Cummings | Chief Medical Officer | $1,212,535 |
| Sean Tucker | Chief Scientific Officer | $1,155,031 |
| Michael Finney | CEO | $305,390 |
| Michael J. Finney | Former Interim Chief Executive Officer | $305,390 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Andrei Floroiu | Former President and Chief Executive Officer | $1,866,844 |
| James Cummings | Chief Medical Officer | $1,174,934 |
| Sean Tucker | Chief Scientific Officer | $1,137,485 |
| Michael Finney | CEO | — |
| Michael J. Finney | Former Interim Chief Executive Officer | — |
| Steven Lo | President and Chief Executive Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Andrei Floroiu | Former President and Chief Executive Officer | $3,589,392 |
| James Cummings | Chief Medical Officer | $1,934,123 |
| Sean Tucker | Chief Scientific Officer | $1,888,689 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Andrei Floroiu | President and Chief Executive Officer | $2,410,175 |
| James Cummings | Chief Medical Officer | $2,379,993 |
| Sean Tucker | Senior Vice President and Chief Scientific Officer | $1,189,150 |
| Margaret A. Echerd | Senior Vice President and Principal Accounting Officer | $1,158,366 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Andrei Floroiu | President and Chief Executive Officer | $2,362,742 |
| Sean Tucker | Senior Vice President and Chief Scientific Officer | $1,224,008 |
| Margaret A. Echerd | Senior Vice President and Principal Accounting Officer | $1,129,695 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Wouter Latour | President and Chief Executive Officer | $747,711 |
| Sean Tucker | Senior Vice President and Chief Scientific Officer | $444,698 |
| Margaret A. Echerd | Senior Vice President and Principal Accounting Officer | $328,952 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Wouter Latour | President and Chief Executive Officer | $850,412 |
| Sean Tucker | Chief Scientific Officer | $378,008 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James B. Breitmeyer, M.D., Ph.D. | member of the Board | Appointed | 2026-04-23 |
| Michael J. Finney, Ph.D. | member of the Science and Technology Committee | Retired | 2025-09-02 |
| Michael J. Finney, Ph.D. | board of directors | Retired | 2025-09-02 |
| Michael J. Finney, Ph.D. | Chair of the Board | Retired | 2025-09-02 |
| Jeroen Grasman | Principal Accounting Officer | Appointed | 2025-05-13 |
| Jeroen Grasman | Chief Financial Officer | Appointed | 2025-05-13 |
| Phillip Lee | Principal Accounting Officer | Resigned | 2025-05-13 |
| Phillip Lee | Chief Financial Officer | Resigned | 2025-05-13 |
| Elaine J. Heron, Ph.D. | Compensation Committee of the Board | Appointed | 2025-01-28 |
| Robert A. Yedid | Board of Directors | Resigned | 2025-01-28 |
| Kevin Finney | Board of Directors | Appointed | 2025-01-28 |
| Robert A. Yedid | Director | Appointed | 2024-06-13 |
| David Wheadon, M.D. | Director | Appointed | 2024-06-13 |
| W. Mark Watson, C.P.A. | Director | Appointed | 2024-06-13 |
| Elaine J. Heron, Ph.D. | Director | Appointed | 2024-06-13 |
| Steven Lo | Director | Appointed | 2024-06-13 |
| Michael J. Finney, Ph.D. | Director | Appointed | 2024-06-13 |
| Steven Lo | member of the Board | Appointed | 2024-03-06 |
| Steven Lo | Chief Executive Officer, President, and principal executive officer | Appointed | 2024-03-06 |
| Michael J. Finney | Interim Chief Executive Officer | Appointed | 2024-01-16 |
| Andrei Floroiu | Member of the Board of Directors | Resigned | 2024-01-16 |
| Andrei Floroiu | President and Chief Executive Officer | Resigned | 2024-01-16 |
| Phillip E. Lee | Principal Accounting Officer | Appointed | 2022-12-19 |
| Phillip E. Lee | Chief Financial Officer | Appointed | 2022-12-19 |
| W. Mark Watson | Compensation Committee | Appointed | 2022-08-25 |